During the past decade, Weill Cornell Medicine - Multiple Myeloma Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Weill Cornell Medicine - Multiple Myeloma Center" #1 collaborator was "Janssen Scientific Affairs, LLC" with 2 trials as a collaborator and "Karyopharm Therapeutics Inc" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Weill Cornell Medicine - Multiple Myeloma Center" are "AL Amyloidosis" (2 trials), "Amyloid" (2 trials), "Refractory Multiple Myeloma" (2 trials), "Amyloidosis" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Weill Cornell Medicine - Multiple Myeloma Center" in a lesser frequency.

Most popular intervention types in "Weill Cornell Medicine - Multiple Myeloma Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (5 trials), "Pomalidomide" (3 trials), "Clarithromycin" (2 trials), "Daratumumab" (2 trials) and "Selinexor" (2 trials). Other intervention names were less common.

The vast majority of trials in "Weill Cornell Medicine - Multiple Myeloma Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Weill Cornell Medicine - Multiple Myeloma Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Weill Cornell Medicine - Multiple Myeloma Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Weill Cornell Medicine - Multiple Myeloma Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".